# Xeris Biopharma Holdings, Inc. (XERS)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/XERS)

## Price

| Indicator | Value |
| --- | --- |
| Current Price | $ 6.53 |
| Market Cap | $ 1.13B |

## Valuation

Widest P/E window this company has the history to fill: 9 years. Shorter windows are still computed; longer ones are left empty rather than padded.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 2.87 |
| Liabilities / Eq | 29.13 |
| Current Ratio | 2.12 |

## Other views

- [Charts](https://sponda.capital/en/XERS/charts.md)
- [Fundamentals](https://sponda.capital/en/XERS/fundamentals.md)
- [Compare](https://sponda.capital/en/XERS/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.